Recombinant proteins were expressed and purified by affinity-chromatography as described previously [10], [11], [16]. Briefly, E. coli XL1-Blue cells were transformed with plasmid PFAOP/pQE30, PFAOPC117S/pQE30, PFAOPC143S/pQE30 or PFAOPL109M/pQE30. Expression was induced with 0.5 mM isopropyl-β-D-1-thiogalactopyranoside for 4 h at 37 °C. Liquid cultures were harvested by centrifugation for 15 min at 4000×g and 4 °C. The bacteria were resuspended in buffer containing 20 mM imidazole, 300 mM NaCl, 50 mM NaxHyPO4, pH 8.0, incubated with lysozyme and disrupted by sonication. Proteins were affinity-purified on Ni-NTA agarose columns and eluted in buffer containing 200 mM imidazol, 300 mM NaCl, 50 mM NaxHyPO4, pH 8.0. Subsequently, samples were treated with 5 mM DTT for 30 min at 4 °C to fully reduce the protein. Remaining imidazole and DTT were removed using HiTrap desalting columns that were equilibrated with buffer containing 100 mM NaxHyPO4, 0.1 mM DTPA, pH 7.4. Protein elution was monitored at 280 nm using an Äkta FPLC system. The protein concentration was determined spectrophotometrically using the molar extinction coefficient ε280 nm = 21.43 mM−1 cm−1 as calculated for the primary sequence of the protein using the ProtParam ExPASy tool (http://web.expasy.org/protparam/). The thiol content of the proteins was analyzed with 5,5′-dithiobis-(2-nitrobenzoic acid) [17] revealing that 97% of the protein thiols were in a reduced state (data not shown).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.